An artificial intelligence (AI) method could revolutionize how we discover new drugs. This approach, spotlighted in recent research published in Science, uses complex data from human cells to speed up drug development.
AI is becoming a game-changer in medicine. Hongkui Deng, a cell biologist at Peking University, says this method creates a “smart” screening system that learns from its own experiments. It’s a big step toward more efficient drug discovery.
Traditionally, researchers have spent years sifting through vast libraries of chemical compounds. They would test each one to see how it affects cells grown in labs. This process has led to breakthroughs, like finding drugs that destroy cancer cells. However, it’s slow and labor-intensive, often screening tens of thousands of compounds.
Alex Shalek, a biomedical engineer at MIT, notes that combining these traditional methods with newer genomic data is often too costly and complicated. To tackle this issue, he worked with a team at Cellarity, a biotech firm, to develop DrugReflector, a deep-learning model trained on data from nearly 9,600 compounds and their effects on over 50 cell types.
This AI system proved to be incredibly efficient. DrugReflector was 17 times better at identifying useful compounds compared to standard methods. It even improved its success rate when it learned from previous results.
Recent statistics show that drug discovery is becoming more dependent on AI, with a 2021 survey revealing that 85% of pharmaceutical companies are exploring AI technologies. This trend suggests that the industry recognizes the need to innovate.
Social media reactions highlight excitement and skepticism around AI in healthcare. Some praise its potential, while others worry about ethics and data privacy.
By streamlining the drug discovery process, AI not only promises to speed up finding new therapies but also opens the door to exploring more complex ways of understanding diseases.
For further reading on the advancements of AI in drug discovery, you can check out this report from the National Institutes of Health.
Source link
Drug discovery,Machine learning,Science,Humanities and Social Sciences,multidisciplinary
